Sequoia’s Lung Cancer Early Detection program is a participating member of the International Early Lung Cancer Action Program (I-ELCAP), administered by the Weill College of Medicine of Cornell University. I-ELCAP is designed specifically for lung cancer screening in patients who do not have symptoms but may meet other qualifying criteria. Patients are age 40 and over, typically with a history of smoking or second hand smoke exposure. Patients who do not qualify for I-ELCAP, or do not want to participate in the trial, will be referred to Sequoia-based lung cancer specialists for a consult. This clinical pathway reflects Sequoia’s unique, comprehensive approach to lung cancer diagnosis and treatment. Sequoia’s Lung Cancer program is overseen by a dedicated program coordinator who provides individual patient education and support.
"With the availability of today's sophisticated, low-dose CT imaging, which is more sensitive than chest X-rays, we hope for improved ability to detect early-stage cancer," adds Dr. Fred Marcus, medical oncologist, emphasizing that early detection complements Sequoia's stellar Lung Cancer program. "Sequoia already stands out as a lung cancer center in this community and we continue to take pride in partnering with faculty from the world-renowned UCSF Medical Center lung cancer program to bring university-level care to this community hospital."
Sequoia is one of 50 institutions worldwide participating in I-ELCAP, the first research study of its kind evaluating the effectiveness of screening for lung cancer with low-dose CT scanning. In addition to revealing the condition of the lungs, the results include the Coronary Artery Calcification score - a marker of heart health. Scans are not free. The cost of a low-dose CT scan is $399, a significantly reduced rate.
Please contact Mirella Massad, program coordinator, at (650) 367-LUNG (5864) with any questions regarding the Lung Cancer Early Detection program or to schedule an appointment.
